Back
  1. Home
  2. Profile of Edith Sépulchre (ULiège)
Profil

Sépulchre Edith

GIGA

See author's contact details
ORCID
0000-0002-6403-3771
Main Referenced Co-authors
Radermecker, Régis  (7)
Bours, Vincent  (5)
Minon, Jean-Marc (5)
Martin, Marie  (3)
Paridaens, Henry (3)
Main Referenced Keywords
diabetes (3); Hematology (2); Acidocétose (1); acute promyelocytic leukemia (1); Alloimmunisation (1);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège (1)
HEC Recherche. Business Analytics & Supply Chain Management - ULiège (1)
Mathematics - ULiège (1)
Main Referenced Disciplines
Oncology (11)
Endocrinology, metabolism & nutrition (8)
Hematology (8)
Pediatrics (5)
Immunology & infectious disease (2)

Publications (total 33)

The most downloaded
5481 downloads
Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503. https://hdl.handle.net/2268/172229

The most cited

13 citations (OpenAlex)

Sepulchre, E., Pittie, G., Stojkovic, V., Haesbroeck, G., Crama, Y., Schyns, M., Paridaens, H., de Marchin, J., Degesves, S., Biemar, C., Boccar, S., Senterre, J.-M., & Minon, J.-M. (2022). Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution. Acta Clinica Belgica, 77 (2), 261-267. doi:10.1080/17843286.2020.1822078 https://hdl.handle.net/2268/249329

Sépulchre, E. (14 March 2025). Unexpected STK11 Gene Deletion in a Breast Cancer Patient: Implications for Cancer Predisposition Panels [Poster presentation]. Congrès de la BeSHG.
Peer reviewed

Sépulchre, E. (14 March 2025). Germline mutational landscape in pediatric cancers and disease relevance [Poster presentation]. Congrès de la BeSHG.
Peer reviewed

Sépulchre, E. (31 January 2025). Germline mutational landscape in pediatric cancers and disease relevance [Paper presentation]. SIOPE HGWG - C4CMMRD tandem meeting, Bern, Switzerland.

Freire Chadrina, M., Martin, M., Segers, K., Sépulchre, E., LEROI, N., COUPIER, J., Kalantari, H. R., Wolter, P., Collignon, J., Polus, M., Plomteux, O., Josse, C., & Bours, V. (29 May 2024). Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of Personalized Medicine, 14 (6), 584. doi:10.3390/jpm14060584
Peer Reviewed verified by ORBi

Gallon, R., Brekelmans, C., Martin, M., Bours, V., Schamschula, E., Amberger, A., Muleris, M., Colas, C., Dekervel, J., De Hertogh, G., COUPIER, J., Colleye, O., Sépulchre, E., Burn, J., Brems, H., Legius, E., & Wimmer, K. (24 May 2024). Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants. npj Precision Oncology, 8 (1), 119. doi:10.1038/s41698-024-00603-z
Peer Reviewed verified by ORBi

Freycon, C., Sépulchre, E., Lavallée, V.-P., Mitchell, D., MacMillan, M. L., Vezina, C., & Goudie, C. (2024). Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review. Clinical Genetics. doi:10.1111/cge.14537
Peer Reviewed verified by ORBi

Sepulchre, E. (21 February 2024). Syndrome de prédisposition au cancer pédiatrique (SPC) [Paper presentation]. Journée des maladies rares - CHU de Liège (Institut de Cancérologie Arsène Burny), Liege, Belgium.

Freycon, C., Sepulchre, E., & Lavallée. (November 2023). Pediatric Acute Promyelocytic Leukemia and Fanconi Anemia: Case report and literature review. Pediatric Blood and Cancer, 70 (S8), 111.
Peer Reviewed verified by ORBi

Sepulchre, E. (November 2023). Germline mutations in DDX41 in a childhood cancer cohort: Prevalence and case report. Pediatric Blood and Cancer, 70 (S8), 281.
Peer Reviewed verified by ORBi

Sépulchre, E. (June 2023). Assessment of Germline Variations Predisposing to Cancer in the Quebec Pediatric Population [Paper presentation]. MIC'Science.

Sepulchre, E. (March 2023). Germline variant curation and incidental findings [Paper presentation]. Provincial Tumor Board.

KAMBALE KOMBI, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., Sepulchre, E., Bours, V., Floc'h, A., Pirenne, F., Kayembe Tshilumba, C., & Batina-Agasa, S. (2022). Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo. Transfusion Medicine. doi:10.1111/tme.12939
Peer Reviewed verified by ORBi

Sepulchre, E., Minon, J.-M., Paridaens, H., Stojkovic, V., Ketelslegers, O., & Dresse, M.-F. (2022). P-044: RETROSPECTIVE STUDY OF POST-TRANSFUSION ALLOIMMUNIZATION IN THE SICKLE CELL POPULATION OF THE CHR CITADELLE. In HemaSphere. EHA. doi:10.1097/01.hs9.0000873072.90171.fd
Peer reviewed

Kambale-Kombi, P., Marini Djang'Eing'A, R., ALWORONG’A OPARA, J., MINON, J., Sepulchre, E., Bours, V., FLOCH, A., PIRENNE, F., KAYEMBE TSHILUMBA, C., & BATINA AGASA, S. (August 2022). P-035: RED BLOOD CELL ALLOIMMUNIZATION IN SICKLE CELL DISEASE PATIENTS IN THE DEMOCRATIC REPUBLIC OF THE CONGO. HemaSphere, 6, 34-34. doi:10.1097/01.hs9.0000873036.01916.17
Peer Reviewed verified by ORBi

Sepulchre, E. (July 2022). Pediatric cancer: When to consider a hereditary predisposition syndrome? [Paper presentation]. Kinshasa Reference Center for Rare and Undiagnosed Diseases seminar, Kinshasa, Congo - Kinshasa.

Sepulchre, E., Pittie, G., Stojkovic, V., Haesbroeck, G., Crama, Y., Schyns, M., Paridaens, H., de Marchin, J., Degesves, S., Biemar, C., Boccar, S., Senterre, J.-M., & Minon, J.-M. (2022). Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution. Acta Clinica Belgica, 77 (2), 261-267. doi:10.1080/17843286.2020.1822078
Peer Reviewed verified by ORBi

Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581
Peer Reviewed verified by ORBi

SEPULCHRE, E., Daubie, V., Adam, A.-S., Cotton, F., & Gulbis, B. (September 2021). Hereditary spherocytosis: How to optimize its diagnosis. Belgian Journal of Paediatrics, 23 (3), 230-5.
Peer Reviewed verified by ORBi

SEPULCHRE, E., Stojkovic, V., Paridaens, H., Senterre, J.-M., & Minon, J.-M. (November 2020). Evaluation of ROCHE Anti-SARS-CoV-2 ECLIA and comparison with 4 other assays. Poster at RBSLM annual meeting [Poster presentation]. Annual meeting of Royal Belgian Society of Laboratory Medicine, Bruxelles, Belgium.
Editorial reviewed

SEPULCHRE, E., Adam, A.-S., Cotton, F., Lazarova, E., & Gulbis, B. (June 2019). Hereditary spherocytosis : screening and diagnostic approach in a Belgian laboratory. HemaSphere, 3 (1), 548. doi:10.1097/01.HS9.0000563096.36433.6b
Peer Reviewed verified by ORBi

Sepulchre, E. (March 2019). Hereditary spherocytosis: How to optimize our diagnostic approach? [Paper presentation]. Red Blood Cell Disorder meeting.

SEPULCHRE, E. (March 2019). La sphérocytose héréditaire en Belgique: Huit années d’expérience diagnostique [Poster presentation]. Congrès annuel de la SFH.
Editorial reviewed

Sepulchre, E. (June 2017). A propos d’une cassure de la courbe pondérale [Paper presentation]. Luxembourg annual pediatric meeting.

Sepulchre, E., Ketelslegers, O., Minon, J.-M., & DRESSE, M.-F. (March 2016). Newborn screening for sickle cell disease : 13 years at the CHR "La Citadelle", Liège. Tijdschrift van de Belgische Kinderarts, 18 (1), 107.
Peer reviewed

RADERMECKER, R., PHILIPS, J.-C., & Sepulchre, E. (March 2015). Analyse rétrospective des données concernant les patientes avec diabète gestationnel au CHU de Liège. Diabetes and Metabolism, 41, 46.
Peer Reviewed verified by ORBi

SEPULCHRE, E. (March 2015). Atypical bifocal intracranial tumor: A case report [Poster presentation]. Congrès annuel de la SBP.
Peer reviewed

RADERMECKER, R., Sepulchre, E., & CONTESSI, E. (March 2014). Enquête concernant les connaissances de l’acido-cétose de patients diabétiques de type 1suivis régulièrement dans la convention hospitalière du CHU. Diabetes and Metabolism, 40, 11.
Peer Reviewed verified by ORBi

SEPULCHRE, E. (March 2014). Interprétation et interférences dans le dosage de l’hémoglobine glyquée : un cas d’HbA1c indosable [Poster presentation]. Congrès annuel de la SFD, Paris, France.
Editorial reviewed

Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503.
Peer reviewed

Sepulchre, E., & RADERMECKER, R. (December 2013). Les inhibiteurs du cotransporteur du glucose SGLT rénal: une nouvelle classe thérapeutique dans le diabète de type 2. Journal de Cardiologie, 25 (8), 429-434.

RADERMECKER, R., & Sepulchre, E. (October 2013). De la molécule au médicament: comment ça se passe? Revue de l'Association Belge du Diabète, 56.
Peer reviewed

RADERMECKER, R., & Sepulchre, E. (March 2013). Mesure continue du glucose et diabète gestationnel : revue des études disponibles. Diabetes and Metabolism, 39, 119-A120.
Peer Reviewed verified by ORBi

RADERMECKER, R., & Sepulchre, E. (January 2013). Les pompes à insulines et les insulines d'aujourd'hui. Urgence Pratique, 116, 23-26.
Peer reviewed

Contact ORBi